Fainting Detection and Early Warning Using a Wearable Monitor
Official title: Fainting Detection And Early Warning In Syncope Evaluation Study
Run by Boston Scientific Corporation · NCT07502599 · Data updated 2026-11-12
This study tests whether signals from a wearable Holter monitor can reflect the severity of orthostatic intolerance in people with fainting disorders.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Boston Scientific Corporation Industry-sponsored |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | August 6, 2026 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | October 14, 2026 |
| Trial ID | NCT07502599 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older who previously completed ARS assessment and were diagnosed with OH, reflex syncope, or normal controls.
✕Probably not a fit
Patients without a prior ARS assessment or those unwilling to wear the monitor or complete follow-up may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This non-randomized feasibility study will enroll up to 40 adults who have had an autonomic reflex screen and were diagnosed with orthostatic hypotension, vasovagal syncope, or were normal controls. Participants will wear a Holter monitor during clinic visits and for a 21-day period to examine how monitor signals relate to symptom severity reported in standard questionnaires. The study includes one in-person visit and follow-up, with separate groups for OH, reflex syncope, and controls, to explore signal patterns and potential early warning indicators. Data analysis will focus on correlating wearable signals with symptom scales and clinical diagnoses.
Why it matters
Potential benefit: If successful, the approach could improve early detection of fainting risk and guide personalized management using wearable monitoring.
How similar studies have gone: Prior studies have explored wearable signals for autonomic disorders, but this specific feasibility approach in OH and vasovagal syncope is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing and capable to provide informed consent * Age 18 or above * Previously underwent a clinically indicated ARS assessment without complications (including deep breathing, Valsalva maneuver, and tilt table testing). * Previously diagnosed with OH, Vasovagal syncope, OR control subjects assessed as normal, based on the ARS assessment. Participant enrollment shall be based on the type of diagnosis. * Willing to complete all required study activities. Exclusion Criteria: * Currently enrolled in another clinical trial that might interfere with data collection. * Subject is pregnant or planning to become pregnant during the study * Active Implantable Medical Device, e.g. cardiac implantable electronic devices, bladder stimulators, diaphragm stimulators, implantable neuro stimulator, implantable active monitoring devices, implantable active drug administration devices, etc. * Have a prosthetic cardiac valve or previously underwent cardiac valve surgery. * Known allergy to materials used in the study (adhesive, ECG electrodes) * Diagnosed with syncope due to cardiologic causes. * Have had a myocardial infarction in the previous 90 days * Have been diagnosed with tachycardia that requires current medical treatment * Have any contraindications for exercise testing, tilt table test, Valsalva maneuver test or deep breathing test (judged by the study Principal Investigator)
Where it's running
-
Mayo Clinic Foundation
Rochester, Minnesota, United States Recruiting
Study contacts
- Study coordinator: Ashley M Jensen, Masters of Science
- Email: ashley.jensen@bsci.com
- Phone: 612-449-2918
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Breathing retraining for pregnant women with POTS
This trial will test whether diaphragmatic breathing exercises help pregnant women with POTS reduce dizziness, rapid heart rate, and other orthostatic symptoms.
-
How blood pressure and heart rate respond to standing and exercise in healthy people and those with high blood pressure
See if blood pressure, heart rate, and arterial stiffness during standing and graded bike exercise differ between healthy young adults and older adults with controlled high blood pressure, including those with orthostatic problems or diabetes.
-
Polish registry of heart nerve–targeting treatments (cardioneuroablation and cardioneuromodulation)
This registry collects information to see how nerve-targeting heart procedures work for adults with fainting, abnormal heart rhythms, or orthostatic problems.
-
Using blood pressure and oxygen measurements to predict fall risk in older adults
This study is trying to see if measuring blood pressure and oxygen levels can help predict fall risks in older adults who have fallen in the past year.
-
Comparing pacemaker therapy and cardioneuroablation for reflex syncope
This study is testing whether a new treatment called cardioneuroablation works better than a pacemaker for people over 40 who have frequent fainting spells caused by slow heart rates.
-
Transcutaneous spinal stimulation to improve blood pressure after a recent spinal cord injury
We will try a noninvasive spinal stimulation to see if it raises and steadies blood pressure in people 7–30 days after a thoracic spinal cord injury who have low blood pressure or dizziness when sitting up.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.